Hospital Financials Have Recovered to Pre-Recession Levels, According to Thomson Reuters Study
The recovery has been broad-based, with all classes of hospitals -- small, medium and large community hospitals, teaching hospitals and major teaching hospitals -- showing positive median margins.
The study tracks two dozen key financial indicators, using proprietary and public data to dissect the balance sheets of more than 400 hospitals nationwide. It evaluates trends in revenue and profit, employment levels, closures, inpatient volume, days cash on hand, and case mix to gauge the fiscal health of the nation's hospitals.
Following are the key findings of the analysis:
-- Total Margins Increase: Median total margins were at 0.37 percent in
Q308. In Q209, they reached 8.4 percent.
-- 20 Percent of Hospitals Still in the Red: About 20 percent of hospitals
had negative total margins in Q209 -- which is similar to the rate seen
before the recession began in late 2007. This is an improvement from
Q109 when 30 percent of hospitals were operating with negative margins
and Q308, when half of U.S. hospitals were operating in the red.
-- Liquidity Improves Significantly: Allaying fears of a hospital credit
crunch, hospitals' median days-cash-on-hand has increased significantly
from 90 days in Q109 to 146 days in Q209 -- which is higher than the
historic long-term average.
-- Labor Costs Cut by Reducing Length of Stay: While hospitals have
maintained a consistent ratio of staffing levels per occupied bed
throughout the recession, total labor costs are down approximately 2.25
percent in Q209 .This reduction in labor expense per discharge has been
achieved by reduction of patient length of stay.
-- Hospital Admissions Increase: Mean patient discharge volumes for all
hospitals began declining shortly after the recession started -- but
moved into positive territory in Q209.
"U.S. hospitals are on track to come out of the recession in better financial shape than they were in when the downturn began," said
Journalists can request a copy of the study from
The Healthcare & Science business of
About
SOURCE
David Wilkins of Thomson Reuters, +1-734-913-3397, David.wilkins@thomsonreuters.com